Roivant Sciences ROIV Balance Sheet Statement
| TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | TTM Q4 '24 | ||
|---|---|---|---|---|---|---|
| $1.42B+1,444% | $91.94M-10.0% | $102.19M+7.8% | $94.79M+0.9% | $93.95M-5.2% | ||
| $2.87B-5.9% | $3.05B-3.1% | $3.15B-3.5% | $3.26B— | —— | ||
| $5.17B+10.9% | $4.66B+3.3% | $4.51B-2.3% | $4.62B-7.7% | $5B-6.8% | ||
| $11.99M-10.9% | $13.45M-47.6% | $25.67M+72.7% | $14.87M+23.3% | $12.06M-11.1% | ||
| $5.71B+9.2% | $5.23B+3.2% | $5.06B+0.6% | $5.03B-7.4% | $5.44B-6.1% | ||
| $18M+35.4% | $13.29M-11.7% | $15.06M+30.4% | $11.55M-51.2% | $23.69M-0.1% | ||
| —— | —— | —— | —— | $1.17M-61.5% | ||
| $281.24M+85.1% | $151.96M+13.5% | $133.86M+17.6% | $113.87M-23.8% | $149.41M+5.6% | ||
| $416.28M+65.8% | $251.14M-2.3% | $257.14M+18.7% | $216.7M-13.2% | $249.74M-2.6% | ||
| $0-100% | $7B0.0% | $7B0.0% | $7B— | $0-100% | ||
| -$501.81M+27.8% | -$695M-62.0% | -$429.11M-36.0% | -$315.59M-372% | $116.06M-74.8% | ||
| $4.53B+6.0% | $4.27B-2.1% | $4.36B+0.4% | $4.35B-7.3% | $4.69B-9.7% | ||
| $5.71B+9.2% | $5.23B+3.2% | $5.06B+0.6% | $5.03B-7.4% | $5.44B-6.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Roivant Sciences's total assets?
- Roivant Sciences (ROIV) holds $5.7B in total assets, up 5.0% year over year.
- How much debt does Roivant Sciences have?
- Roivant Sciences carries $107.4M in total debt against $4.5B of shareholders' equity, a debt-to-equity ratio of 0.02.
- How much cash does Roivant Sciences have?
- Roivant Sciences holds $1.4B in cash and equivalents.
- Can Roivant Sciences cover its short-term obligations?
- Its current ratio is 18.37 — current assets exceed current liabilities.
- Where does Roivant Sciences's balance sheet data come from?
- Every line is extracted from Roivant Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
